Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP1 | P11387 | 4/20 | 0.65 |
| ▸ | CYCS | P99999 | 3/20 | 0.63 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.61 |
| ▸ | TERT | O14746 | 4/20 | 0.57 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4109032 | 0.98 | TOP1 (0.63) | TOP1CYCSENPP2TERTABCG2 | |
| SCHEMBL29817713 | 0.98 | TOP1 (0.63) | TOP1CYCSENPP2TERTABCG2 | |
| SCHEMBL2337788 | 0.98 | TOP1 (0.63) | TOP1CYCSENPP2TERTABCG2 | |
| Hydrochloric Acid SCHEMBL30735631 | 0.98 | TOP1 (0.63) | TOP1CYCSENPP2TERTABCG2 | |
| SCHEMBL29801701 | 0.98 | TOP1 (0.63) | TOP1CYCSENPP2TERTABCG2 | |
| SCHEMBL6292613 | 0.93 | TOP1 (0.62) | TOP1CYCSENPP2TERTABCG2 | |
| SCHEMBL14181445 | 0.93 | TOP1 (0.62) | TOP1CYCSENPP2TERTABCG2 | |
| SCHEMBL29585765 | 0.93 | TOP1 (0.62) | TOP1CYCSENPP2TERTABCG2 | |
| SCHEMBL29403816 | 0.93 | TOP1 (0.62) | TOP1CYCSENPP2TERTABCG2 | |
| SCHEMBL28049797 | 0.93 | TOP1 (0.62) | TOP1CYCSENPP2TERTABCG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 555 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12565426-B2 | Photothermal catalytic method for production of hydrogen peroxide without sacrificial reagents on basis of porphyrin-based supermolecule | JIANGNAN UNIVERSITY (CN) | 2026-03-03 | — | — | US | claimed |
| CN-119507008-A | Magnesium/magnesium alloy material of antibacterial and anticorrosive composite coating and preparation method thereof | 山东科技大学 | 2025-02-25 | — | — | CN | claimed |
| CN-119060010-B | CO (carbon monoxide)2Method for preparing cyclic carbonate by adding epoxide | 广东石油化工学院 | 2025-02-11 | — | — | CN | claimed |
| CN-115433565-B | Preparation method of ratio type fluorescent probe for detecting nucleic acid amplification product | 苏州卫生职业技术学院 | 2024-06-04 | — | — | CN | claimed |
| CN-116143792-B | Active oxygen response non-light source photodynamic therapy photosensitive molecule and preparation method and application thereof | 浙江大学 | 2024-04-05 | — | — | CN | claimed |
| CN-117797781-A | Chitosan-porphyrin supermolecular polymer network dye adsorbent and preparation method and application thereof | 山西大学 | 2024-04-02 | — | — | CN | claimed |
| CN-117476951-A | Proton exchange membrane fuel cell catalytic layer slurry and preparation method and application thereof | 武汉大学 | 2024-01-30 | — | — | CN | claimed |
| CN-117358309-A | Porphyrin/metal sulfide composite photocatalyst and preparation method thereof | 中国石油大学(华东) | 2024-01-09 | — | — | CN | claimed |
| CN-117304497-A | Iridium dioxide composite metal organic framework material and application thereof | 临沂大学 | 2023-12-29 | — | — | CN | claimed |
| CN-114591730-B | Single-component near-infrared afterglow imaging nano probe and preparation method thereof | 南京邮电大学 | 2023-11-24 | — | — | CN | claimed |
| US-20050250765-A1 | Diazepinones as antiviral agents | CHO HIDETSURA | 2005-11-10 | — | — | US | claimed |
| US-20040185324-A1 | Methanol fuel cells | BEN-GURION UNIVERSITY OF THE NEGEV (IL) | 2004-09-23 | — | — | US | claimed |
| US-20040116410-A1 | Diazepinones as antiviral agents | CHO HIDETSURA (JP) | 2004-06-17 | — | — | US | claimed |
| WO-2002091502-A2 | IMPROVEMENTS IN METHANOL FUEL CELLS | BEN-GURION UNIVERSITY OF THE NEGEV (IL) | 2002-11-14 | — | — | WO | claimed |
| US-5622685-A | TUMOR ACTIVE OR TUMOR DIAGNOSTIC SUBSTANCES WHICH EXHIBIT PREFERRED ACCUMULATION IN TUMOR; REDUCED SIDE EFFECTS | DEUTCHES KREBSFORCHUNSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS (DE) | 1997-04-22 | — | — | US | claimed |
| US-5281616-A | Treatment of human immunodeficiency virus infections | GEORGIA STATE UNIVERSITY FOUNDATION, INC. (US) | 1994-01-25 | — | — | US | claimed |
| US-5192788-A | PORPHYRIN ANTIVIRAL COMPOSITIONS | GEORGIA STATE UNIVERSITY FOUNDATION, INC. (US) | 1993-03-09 | — | — | US | claimed |
| US-5109016-A | Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions | GEORGIA STATE UNIVERSITY FOUNDATION, INC. (US) | 1992-04-28 | — | — | US | claimed |
| EP-0376689-A2 | Polymeric films of metalloporphyrins as conductive materials for electrocatalysis | IDAHO RESEARCH FOUNDATION, INC. (US) | 1990-07-04 | — | — | EP | claimed |
| WO-1989011277-A2 | PORPHYRIN AND PHTHALOCYANINE ANTIVIRAL COMPOSITIONS | GEORGIA STATE UNIVERSITY FOUNDATION, INC. (US) | 1989-11-30 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12565426-B2 | Photothermal catalytic method for production of hydrogen peroxide without sacrificial reagents on basis of porphyrin-based supermolecule | TPO, PPOX, THPO | TOP1 446/4885CYCS 282/4885ENPP2 3226/4885 |
| US-20050250765-A1 | Diazepinones as antiviral agents | ZC3HAV1, ECI1, ZC3HAV1L | TOP1 106/4885CYCS 2705/4885ENPP2 1287/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.